ALPS Medical Breakthroughs ETF

Shareclass
ALPS Medical Breakthroughs ETF (SBIO)
Type
Exchange-traded fund
Manager

Equity & Justice

Exclusions







EQUITY & JUSTICE RATINGS

Gender Equality
Diversity Disclosures
Racial Justice
LGBTQ+ Equity

GENDER EQUALITY

Fund ALPS Medical Breakthroughs ETF

FUND COVERAGE
# of holdings26
% of assets53%
Score
35 / 100
Rank

0.3 percentile

Group: Sector Equity

Rank: #863 out of 865

Grade
F

Gender equality ratings are calculated using data from the Equileap Gender Equality Scorecard from Equileap.

Sub-scores & KPIs

Gender Equality: Gender Balance in Leadership and Workforce

20 / 40

Gender Equality: Equal Compensation and Work Life Balance

4 / 30

Gender Equality: Policies Promoting Gender Equality

11 / 20

Gender Equality: Commitment, Transparency, and Accountability

0 / 10

Fund Holdings: Gender Equality

Highest scoring holdings

Highest scoring holdings

Top 10 holdings by Gender Equality score

  • Holding
    % invested
    USD$
  • 1. Cytokinetics Inc
         % of fund invested: 3.4%
         $USD invested: $2.87M
  • 2. Alkermes PLC
         % of fund invested: 2.25%
         $USD invested: $1.91M
  • 3. Galapagos NV ADR
         % of fund invested: 0.96%
         $USD invested: $809,341
  • 4. Agios Pharmaceuticals Inc
         % of fund invested: 1.13%
         $USD invested: $952,837
  • 5. Arcellx Inc
         % of fund invested: 2.14%
         $USD invested: $1.81M
  • 6. Denali Therapeutics Inc
         % of fund invested: 1.07%
         $USD invested: $902,140
  • 7. Axsome Therapeutics Inc
         % of fund invested: 3.11%
         $USD invested: $2.63M
  • 8. Apellis Pharmaceuticals Inc
         % of fund invested: 1.27%
         $USD invested: $1.08M
  • 9. Amicus Therapeutics Inc
         % of fund invested: 1.26%
         $USD invested: $1.07M
  • 10. PTC Therapeutics Inc
         % of fund invested: 2.38%
         $USD invested: $2.01M
Lowest scoring holdings

Lowest scoring holdings

Bottom 10 holdings by Gender Equality score

  • Holding
    % invested
    USD$
  • 1. Nuvalent Inc Class A
         % of fund invested: 2.9%
         $USD invested: $2.45M
  • 2. Viking Therapeutics Inc
         % of fund invested: 1.97%
         $USD invested: $1.67M
  • 3. Vaxcyte Inc Ordinary Shares
         % of fund invested: 2.61%
         $USD invested: $2.2M
  • 4. Edgewise Therapeutics Inc
         % of fund invested: 0.88%
         $USD invested: $745,915
  • 5. Arrowhead Pharmaceuticals Inc
         % of fund invested: 2.6%
         $USD invested: $2.2M
  • 6. ACADIA Pharmaceuticals Inc
         % of fund invested: 1.73%
         $USD invested: $1.46M
  • 7. Xenon Pharmaceuticals Inc
         % of fund invested: 1.47%
         $USD invested: $1.25M
  • 8. Protagonist Therapeutics Inc
         % of fund invested: 2.17%
         $USD invested: $1.83M
  • 9. Vericel Corp
         % of fund invested: 0.76%
         $USD invested: $638,723
  • 10. Crinetics Pharmaceuticals Inc
         % of fund invested: 1.95%
         $USD invested: $1.65M

Fund manager statement

We invite fund managers to take our survey and provide more information on how they integrate principles of justice and equity in their investment strategy.

Manager survey




EXCLUSION RATINGS

Prisons & Borders
Military Weapons

PRISONS & BORDERS

Fund ALPS Medical Breakthroughs ETF

Totals

Holdings
Assets
Weight
Prisons
0
$0
0%
     Prisons high risk
0
$0
0%
     Private prisons
0
$0
0%
Borders
0
$0
0%
     Borders high risk
0
$0
0%
Total
0
$0
0%
Full fund results

Holdings — 0 flagged holdings

More from Invest Your Values
See how mutual funds and ETFs are rated on issues ranging from fossil fuels, to deforestation, gender equality, guns, prisons, weapons, and tobacco

Disclaimer: As You Sow is not an investment adviser

As You Sow is not an investment adviser as that term is defined under federal and state (California) laws and regulations. As You Sow is a tax-exempt, nonprofit organization dedicated to educating and empowering shareholders to change corporations for the good through the collection, analysis and dissemination of relevant information to the public, free of charge. As You Sow does not provide financial planning, legal or tax advice. Nothing on this website shall constitute or be construed as an offering of financial instruments, or as investment advice or investment recommendations.
See our full disclaimer